AstraZeneca SG&A Expenses 2010-2024 | AZN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual sg&a expenses for 2023 were $19.755B, a 4.22% increase from 2022.
AstraZeneca annual sg&a expenses for 2022 were $18.955B, a 20.89% increase from 2021.
AstraZeneca annual sg&a expenses for 2021 were $15.68B, a 34.1% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual sg&a expenses for 2023 were $19.755B, a 4.22% increase from 2022.
AstraZeneca annual sg&a expenses for 2022 were $18.955B, a 20.89% increase from 2021.
AstraZeneca annual sg&a expenses for 2021 were $15.68B, a 34.1% increase from 2020.